Clinical Trials
The Clearview Cancer Center of Huntsville Hospital has been selected as one of the three primary sites in Alabama for STAR(P-2), a breast cancer prevention trial.
STAR is a Phase III, double-blind trial that will randomize eligible postmenopausal women to either daily Tamoxifen or Raloxifene therapy for 5 years. Trial participants will also complete at least 2 additional years of follow-up.
For additional information on this trial and others that are available at Huntsville Hospital, please go to:
The Clearview Cancer Institute http://www.ccihsv.com/clinical_trials.htm